Chemotherapy for Breast Cancer

NewsGuard 100/100 Score

Chemotherapy is a common treatment for women who have breast cancer. In most cases, it is used in combination with other techniques such as surgical mastectomy, radiotherapy, and hormonal therapy. However, it may be used as a stand-alone treatment in some cases, such as for advanced stage breast cancer.

IV drip hospital patient

Chemotherapy is a cytotoxic treatment that works to destroy quickly dividing cells such as the cancerous cells. It is a systemic treatment that affects the whole body and, as a result, it is associated with significant adverse effects in various areas of the body, particularly those that involve quickly dividing cells (e.g. hair and skin).

Use of chemotherapy for breast cancer

There are several points at which chemotherapy may be used for patients with breast cancer.

Following surgery: Chemotherapy is given following breast surgery that removes areas of the breast that are affected by cancerous growth. In this case, chemotherapy is an adjuvant treatment to destroy any remaining cells that remain after surgery. This is also known as adjuvant chemotherapy.

Before surgery: Chemotherapy is given before surgery to shrink the tumor and reduce the invasiveness of the surgical procedure, which is useful for locally advanced cancer. This is also known as neoadjuvant chemotherapy.

For advanced stage: Chemotherapy is given as the primary treatment for patients with breast cancer that has metastasized because this allows for the simultaneous treatment of cancerous growth in various parts of the body.

Chemotherapeutic agents for breast cancer

There are many different chemotherapeutic agents that may be used in the treatment of breast cancer. In most cases, these agents are used in combination to provide more effective treatment.

The type chemotherapeutic agent or combination used depends on the particular incident and the patient response to treatment. It’s not currently clear if there is one combination that is superior, so various options may be tried and adjusted according to the response of the patient.

Administration of chemotherapy for breast cancer

A dose of chemotherapy is usually administered with intravenous (IV) infusion over several minutes or hours.

It is usually given in cycles with a rest period between each cycle to allow the body to recover from the adverse effects associated with the treatment. The length of each cycle and rest period will depend on the agents that are being used in therapy. In some cases, there will be only one day of administration, followed by a rest period of several weeks, whereas other regimens may have several days of administration or once weekly administration.

The duration of chemotherapy treatment for breast cancer varies widely but is typically between three and six months, depending on the characteristics of cancer and the treatment plan.

Adverse effects of chemotherapy

There are many adverse effects associated with chemotherapy due to the systemic action of the treatment and the broad cytotoxic effect it has on the body. Rapidly dividing cells in the body, such as those in epithelial linings, are most commonly affected.

Immediate adverse effects of chemotherapy for patients with breast cancer may include:

  • Alopecia (loss of hair)
  • Changes to skin and nails
  • Mouth ulcers
  • Changes in appetite
  • Increased risk of infection
  • Bruising or bleeding more easily
  • Fatigue
  • Nausea and vomiting
  • Diarrhea

There are also some delayed effects that may present after the conclusion of chemotherapy. Some patients notice abnormal sensations in the extremities of the body due to neuropathy. Hand-foot syndrome, with symptoms of irritation on the palms of the hands and soles of the feet, may also be reported after some chemotherapy regimens. Cognitive impairment or reduced mental clarity often referred to as chemo brain, is another delayed side effect. Patients may also report feeling more tired for several months or longer after treatment and may have an increased risk of cardiovascular damage, infertility or menstrual changes and leukemia.

References

  1. http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-treating-chemotherapy
  2. https://www.cancerresearchuk.org/
  3. https://www.breastcancercare.org.uk/information-support/facing-breast-cancer/going-through-treatment-breast-cancer/chemotherapy
  4. http://emedicine.medscape.com/article/2006464-overview#showall

Further Reading

Last Updated: May 25, 2023

Yolanda Smith

Written by

Yolanda Smith

Yolanda graduated with a Bachelor of Pharmacy at the University of South Australia and has experience working in both Australia and Italy. She is passionate about how medicine, diet and lifestyle affect our health and enjoys helping people understand this. In her spare time she loves to explore the world and learn about new cultures and languages.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Smith, Yolanda. (2023, May 25). Chemotherapy for Breast Cancer. News-Medical. Retrieved on May 04, 2024 from https://www.news-medical.net/health/Chemotherapy-for-Breast-Cancer.aspx.

  • MLA

    Smith, Yolanda. "Chemotherapy for Breast Cancer". News-Medical. 04 May 2024. <https://www.news-medical.net/health/Chemotherapy-for-Breast-Cancer.aspx>.

  • Chicago

    Smith, Yolanda. "Chemotherapy for Breast Cancer". News-Medical. https://www.news-medical.net/health/Chemotherapy-for-Breast-Cancer.aspx. (accessed May 04, 2024).

  • Harvard

    Smith, Yolanda. 2023. Chemotherapy for Breast Cancer. News-Medical, viewed 04 May 2024, https://www.news-medical.net/health/Chemotherapy-for-Breast-Cancer.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer